PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
ACRP30 102 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.01 0.54
ACRP30 102 Target Target CD4 112,219 1 0.00 -1.00 0.01 0.54
ACRP30 102 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.01 0.55
ACRP30 102 Target Target Renin 43,456 1 0.00 -1.00 0.01 0.56
ACRP30 102 Target Target EGF 27,487 1 0.00 -1.00 0.01 0.57
ACRP30 102 Target Disease Glioblastoma 17,933 1 0.00 -1.00 0.01 0.58
ACRP30 102 Target Disease Non Insulin Dependent Diabetes Mellitus 6,686 1 0.00 -1.00 0.01 0.61
ACRP30 102 Target Target Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 1 0.00 -1.00 0.01 0.61
ACT-2 127 Target Disease Pain 409,851 1 0.00 -1.00 0.01 0.51
ACT-2 127 Target Disease Shock 134,031 1 0.00 -1.00 0.01 0.53
ACT-2 127 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
ACT-2 127 Target Disease Contraception 21,402 1 0.00 -1.00 0.01 0.58
ACT-2 127 Target Disease Cardiac Arrest 20,700 1 0.00 -1.00 0.01 0.58
ACT-2 127 Target Disease HIV/AIDS 20,397 1 0.00 -1.00 0.01 0.58
ACT-2 127 Target Target APOE 12,771 1 0.00 -1.00 0.01 0.59
ACT-2 127 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.01 0.59
ACT-2 127 Target Target BRAF 4,766 1 0.00 -1.00 0.01 0.62
ACT-2 127 Target Disease Histoplasmosis 4,583 1 0.00 -1.00 0.01 0.62
ACT-2 127 Target Target D(2) Dopamine Receptor 1,559 1 0.00 -1.00 0.01 0.65
ACT-2 127 Target Target Bivalirudin 891 1 0.00 -1.00 0.01 0.67
ACTG1 41 Target Disease Inflammation 252,734 1 0.00 -0.99 0.02 0.54
ACTG1 41 Target Disease Breast Cancer 173,695 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Hepatitis 163,842 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Tuberculosis 146,217 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Shock 134,031 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Hepatitis B 57,815 1 0.00 -0.99 0.02 0.57
ACTG1 41 Target Disease Disabilities 28,757 1 0.00 -0.99 0.02 0.59
ACTG1 41 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.99 0.02 0.61
ACTG1 41 Target Disease Retinitis 9,116 1 0.00 -0.99 0.02 0.62
ACTG1 41 Target Disease Acute Promyelocytic Leukemia 4,780 1 0.00 -0.99 0.02 0.63
ACTG1 41 Target Target B2M 677 1 0.01 -0.99 0.02 0.69
ACTG1 41 Target Target AHSG 176 1 0.01 -0.98 0.02 0.74
ACTG1 41 Target Target CALR 117 1 0.01 -0.98 0.02 0.76
ACVR1B 23 Target Disease Inflammation 252,734 1 0.00 -0.98 0.04 0.55
ACVR1B 23 Target Disease Breast Cancer 173,695 1 0.00 -0.98 0.04 0.56
ACVR1B 23 Target Disease Asthma 109,610 1 0.00 -0.98 0.04 0.57
ACVR1B 23 Target Disease Dyslipidemia 15,225 1 0.00 -0.98 0.04 0.61
ACVR1B 23 Target Target Endoglin 1,333 1 0.01 -0.98 0.04 0.68
ACVR1B 23 Target Target ERBB3 1,154 1 0.01 -0.98 0.04 0.68
ACY1 51 Target Target CD34 24,598 1 0.00 -0.99 0.02 0.59
ACY1 51 Target Target BDNF 11,163 1 0.00 -0.99 0.02 0.61
ACY1 51 Target Target AXL 633 1 0.01 -0.99 0.02 0.69
ADRBK1 10 Target Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
ADRBK1 10 Target Disease Cholesterol 182,390 1 0.00 -0.95 0.10 0.57
ADRBK1 10 Target Disease Hepatitis 163,842 1 0.00 -0.95 0.10 0.57
ADRBK1 10 Target Disease Stroke 146,992 1 0.00 -0.95 0.10 0.58
ADRBK1 10 Target Disease Malaria 56,215 1 0.00 -0.95 0.10 0.60
ADRBK1 10 Target Disease Attention Deficit Hyperactivity Disorder 14,687 1 0.00 -0.95 0.10 0.63
ADRBK1 10 Target Disease Yellow Fever 4,081 1 0.00 -0.95 0.10 0.66
ADRBK2 8 Target Disease Carcinoma 433,099 1 0.00 -0.94 0.12 0.56